Poloso et al., Mol Immunol 2002
:
GPI-GM-CSF retained functional activity to induce bone marrow cell proliferation and administration of GPI-GM-CSF expressing membranes induced the generation of DCs in vivo
Torres-Aguilar et al., Ann Rheum Dis 2012
(Antiphospholipid Syndrome) :
Human monocyte derived DCs treated with interleukin (IL)-10 and transforming growth factor ß-1 ( 10/TGF-DC ) induced ß ( 2 ) GPI-specific-unresponsiveness in effector/memory CD4 ( + ) T cells ( 46.5 % ± 26.0 less proliferation ) in 16 of 20 analysed patients with APS, without affecting the proliferative response to an unrelated candidin